
Rohtak Nuclear Medcare LLP
About Rohtak Nuclear Medcare LLP
Data last updated:
Rohtak Nuclear Medcare LLP is a limited liability partnership (LLP) based in Rohtak, Haryana, India, recognised as a startup by DPIIT. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 16 October 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAK-8892. Its GSTIN is 06AAWFR8619J1ZD (Haryana).
The LLP has a total obligation of contribution of ₹7.58 Cr. It is led by designated partners including Parveen Kundu and Manju.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 2453 Sector – 1, Rohtak, Haryana, India – 124001.
As per the financials filed for FY 2025, the LLP reported a revenue of ₹6.35 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹38.17 Lakh (net margin 6%) and EBITDA of ₹1.33 Cr (EBITDA margin 20.9%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years.
As per MCA filings, the LLP has open charges of ₹1.53 Cr on record. Court records list 6 cases involving the LLP, including 6 filed against it.
Rohtak Nuclear Medcare LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-16-0007843).
Company details
Recognitions & Rankings of Rohtak Nuclear Medcare
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-16-0007843
Contact details
Rohtak Nuclear Medcare LLP's registered office is in Rohtak, Haryana.
- Registered Address2453 Sector – 1, Rohtak, Haryana, India – 124001
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rohtak Nuclear Medcare LLP
FY 2025 filings availableRohtak Nuclear Medcare LLP reported revenue of ₹6.35 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over three years, including 33% growth in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹38.17 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 6% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Rohtak Nuclear Medcare LLP, buy the company report.
Designated partners of Rohtak Nuclear Medcare LLP
Rohtak Nuclear Medcare has 3 current designated partners and 7 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parveen Kundu Also directs: Nuctherain Private Limited | Designated Partner | 16 Oct 2017 | 9 Years 0 Months | Current |
| Manju | Designated Partner | 04 Jul 2022 | 4 Years 3 Months | Current |
| Sajni Devi | Designated Partner | 04 Jul 2022 | 4 Years 3 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jul 2018 | 100198748 | State Bank of India | ₹1.53 Cr | Open |
To see the full charge records of Rohtak Nuclear Medcare LLP, buy the company report.
Total charge records: 1 View all charges
Legal cases
Rohtak Nuclear Medcare LLP has 6 court cases on record: 6 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 0 |
Cases on record (2 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Ms Transasia Bio Medicals Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Ms Transasia Bio Medicals Ltd | Disposed |
To see the full case history of Rohtak Nuclear Medcare LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rohtak Nuclear Medcare LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rohtak Nuclear Medcare has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAWFR8619J1ZD | Haryana | Active | 23 Nov 2017 |
To see the full GST registrations and return filing status of Rohtak Nuclear Medcare LLP, buy the company report.
Recent activity
Rohtak Nuclear Medcare LLP has 11 designated partner changes on record since 2017: 8 appointments and 3 cessations. The latest: Dharamveer Mahecha was appointed as Partner on 06 Sep 2024.
4 earlier events are in the company report.
Frequently asked questions
Rohtak Nuclear Medcare is an active limited liability partnership based in Rohtak, Haryana, India. The LLP works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 16 October 2017 (9+ years old) and is registered under LLPIN AAK-8892.
Rohtak Nuclear Medcare has 3 current designated partners:
- Parveen Kundu - Designated Partner
- Manju - Designated Partner
- Sajni Devi - Designated Partner
The latest financial statements of Rohtak Nuclear Medcare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Rohtak Nuclear Medcare is 06AAWFR8619J1ZD, registered in Haryana.
The LLPIN (Limited Liability Partnership Identification Number) of Rohtak Nuclear Medcare is AAK-8892. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Rohtak Nuclear Medcare has 6 court cases on record: 6 filed against it.
Rohtak Nuclear Medcare was incorporated on 16 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Dharamveer Mahecha was appointed as Partner on 06 Sep 2024. Dinesh Kundu was appointed as Partner on 06 Sep 2024. Mitul Agarwal was appointed as Partner on 06 Sep 2024. Rohtak Nuclear Medcare has 11 designated partner changes on record in total.
Yes, Rohtak Nuclear Medcare is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Rohtak Nuclear Medcare is registered as a small enterprise under Udyam registration (number: UDYAM-HR-16-0007843).